Speaker illustration

Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)

Dr. Paul Ridker serves as the Eugene Braunwald Professor of Medicine ant the Harvard Medical School and as Director of the Center for Cardiovascular Disease Prevention at the Brigham and Women's Hospital, Boston, Massachusetts, USA. With research interests including inflammation biology, lipids, atherosclerosis, epidemiology, and prevention, Dr. Ridker has also designed and conducted a large number of multi-national trials funded by the NIH or industry including JUPITER, SPIRE-1, SPIRE-2, PREVENT, CANTOS, and CIRT. He currently is Co-Chair of the ongoing PROMINENT study.

Anti-inflammatory drugs in cardiovascular disease: current and novel approaches

Event: ESC Congress 2024

Topic: Cardiovascular Pharmacotherapy

Session type: Practical Seminar

Thumbnail

Systemic inflammation in stable and unstable ischaemic heart disease (IHD): connecting the dots

Event: ESC Congress 2024

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Session type: Satellite Symposium

Thumbnail

Inflammation: the next target in atherosclerotic cardiovascular disease care?

Event: ESC Congress 2023

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Session type: Satellite Symposium

Thumbnail

Young Investigator Award Session Population Sciences

Event: ESC Congress 2020

Topic: Risk Factors and Prevention

Session type: Award Sessions

Thumbnail

PCSK9 inhibition - cholesterol reduction and beyond

Event: ESC Congress 2017

Topic: Lipids (Epidemiology and Prevention)

Session type: Symposium

Thumbnail